These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2316314

  • 41. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment.
    Colao A, Di Sarno A, Sarnacchiaro F, Ferone D, Di Renzo G, Merola B, Annunziato L, Lombardi G.
    J Clin Endocrinol Metab; 1997 Mar; 82(3):876-83. PubMed ID: 9062500
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies.
    Ahmed M, al-Dossary E, Woodhouse NJ.
    Fertil Steril; 1992 Sep; 58(3):492-7. PubMed ID: 1521641
    [Abstract] [Full Text] [Related]

  • 49. [Treatment of prolactin-secreting pituitary tumors with bromocriptine].
    Katzir D, Rosenberg T, Ramot Y, Gaver-Shavit A, Gilboa Y.
    Harefuah; 1990 Feb 01; 118(3):141-5. PubMed ID: 2341064
    [Abstract] [Full Text] [Related]

  • 50. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E, Camanni F.
    Drugs; 1996 Jun 01; 51(6):954-65. PubMed ID: 8736617
    [Abstract] [Full Text] [Related]

  • 51. [Results of treatment for acromegaly with long-acting bromocriptine (Parlodel LAR)].
    Bednarek-Tupikowska G, Bohdanowicz-Pawlak A, Bolanowski M, Jedrzejak J, Milewicz A.
    Endokrynol Pol; 1993 Jun 01; 44(2):161-8. PubMed ID: 8055787
    [Abstract] [Full Text] [Related]

  • 52. The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemia.
    Bolanowski M, Milewicz A, Bohdanowicz-Pawlak A, Bednarek-Tupikowska G, Jedrzejak JA, Lancranjan I.
    Endokrynol Pol; 1993 Jun 01; 44(4):467-76. PubMed ID: 8055815
    [Abstract] [Full Text] [Related]

  • 53. Resistance to bromocriptine in prolactinomas.
    Pellegrini I, Rasolonjanahary R, Gunz G, Bertrand P, Delivet S, Jedynak CP, Kordon C, Peillon F, Jaquet P, Enjalbert A.
    J Clin Endocrinol Metab; 1989 Sep 01; 69(3):500-9. PubMed ID: 2760167
    [Abstract] [Full Text] [Related]

  • 54. Giant invasive prolactinoma: a case report and review of nine further cases.
    Davis JR, Sheppard MC, Heath DA.
    Q J Med; 1990 Mar 01; 74(275):227-38. PubMed ID: 2385731
    [Abstract] [Full Text] [Related]

  • 55. Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.
    Höfle G, Gasser R, Mohsenipour I, Finkenstedt G.
    Exp Clin Endocrinol Diabetes; 1998 Mar 01; 106(3):211-6. PubMed ID: 9710362
    [Abstract] [Full Text] [Related]

  • 56. Effect of different dopaminergic agents in the treatment of acromegaly.
    Colao A, Ferone D, Marzullo P, Di Sarno A, Cerbone G, Sarnacchiaro F, Cirillo S, Merola B, Lombardi G.
    J Clin Endocrinol Metab; 1997 Feb 01; 82(2):518-23. PubMed ID: 9024247
    [Abstract] [Full Text] [Related]

  • 57. Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemia.
    Merola B, Colao A, Caruso E, Sarnacchiaro F, Lancranjan I, Lombardi G, Schettini G.
    J Endocrinol Invest; 1992 Mar 01; 15(3):173-6. PubMed ID: 1624676
    [Abstract] [Full Text] [Related]

  • 58. Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.
    Abs R, Parizel PM, Beckers A.
    J Endocrinol Invest; 1991 Feb 01; 14(2):135-8. PubMed ID: 1905737
    [Abstract] [Full Text] [Related]

  • 59. Visual function improvement in patients with macroprolactinomas treated with bromocriptine.
    Lesser RL, Zheutlin JD, Boghen D, Odel JG, Robbins RJ.
    Am J Ophthalmol; 1990 May 15; 109(5):535-43. PubMed ID: 2333917
    [Abstract] [Full Text] [Related]

  • 60. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
    Sabuncu T, Arikan E, Tasan E, Hatemi H.
    Intern Med; 2001 Sep 15; 40(9):857-61. PubMed ID: 11579944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.